Treated with JNK inhibitor blocked the effect of IL-33 on promoting cell migration (Figure 4B, 4C and Supplementary Figure 3A, 3B) and invasion in both glioma cell lines (Figure 4D, 4E and Supplementary Figure 3C). The gene discussed is IL33; the disease is central nervous system cancer.